Movers

First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday

U.S. stocks were mixed, with the Dow Jones index gaining around 100 points on Monday.

Shares of First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX) rose sharply after the company released topline results from Cohort 1 of its Phase 1b clinical trial of ANB033 in celiac disease.

The clinical-stage biotechnology firm designed ANB033 as an investigational, subcutaneously administered CD122 antagonist to block IL-15 and IL-2 signaling on immune cells. During a 14-day gluten challenge, the candidate protected against gluten-induced intestinal damage and prevented symptom aggravation in study subjects.

First Tracks Biotherapeutics shares jumped 18% to $37.36 on Monday.

Here are some other big stocks recording gains in today’s session.

    • C3.ai, Inc. (NYSE:AI) rose 10.7% to $12.75 after Northland upgraded the stock to Outperform from Market Perform and raised its price target to $16 from $10.
    • Liquidia Corporation (NASDAQ:LQDA) gained 8.4% to $29.70.
    • Borr Drilling Limited (NYSE:BORR) climbed 8.3% to $5.17.
    • Allot Ltd. (NASDAQ:ALLT) rose 8.1% to $9.07.
    • CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC) gained 7.6% to $7.55 after reports suggesting that GTCR and Elliott Investment Management are close to a deal to acquire the company.
    • American Bitcoin Corp (NASDAQ:ABTC) rose 7% to $8.27. HC Wainwright & Co. analyst Mike Colonnese assumed American Bitcoin with a Buy rating and announced a price target of $22.
    • Cypherpunk Technologies Inc. (NASDAQ:CYPH) gained 6.3% to $3.14.
    • Manhattan Associates, Inc. (NASDAQ:MANH) rose 6.2% to $217.49.
    • Okeanis Eco Tankers Corp. (NYSE:ECO) gained 6% to $98.68.
    • AST SpaceMobile, Inc. (NASDAQ:ASTS) rose 6% to $54.05 after Deutsche Bank upgraded its rating on the stock from Hold to Buy and maintained its $93 price target.

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.